首页> 美国卫生研究院文献>International Journal of Nanomedicine >Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica
【2h】

Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica

机译:有序纳米多孔二氧化硅作为载体改善水不溶性药物的递送:三维大孔二氧化硅与二维大孔二氧化硅的比较研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The goal of the present study was to compare the drug release properties and stability of the nanoporous silica with different pore architectures as a matrix for improved delivery of poorly soluble drugs. For this purpose, three dimensional ordered macroporous (3DOM) silica with 3D continuous and interconnected macropores of different sizes (200 nm and 500 nm) and classic mesoporous silica (ie, Mobil Composition of Matter [MCM]-41 and Santa Barbara Amorphous [SBA]-15) with well-ordered two dimensional (2D) cylindrical mesopores were successfully fabricated and then loaded with the model drug indomethacin (IMC) via the solvent deposition method. Scanning electron microscopy (SEM), N2 adsorption, differential scanning calorimetry (DSC), and X-ray diffraction (XRD) were applied to systematically characterize all IMC-loaded nanoporous silica formulations, evidencing the successful inclusion of IMC into nanopores, the reduced crystallinity, and finally accelerated dissolution of IMC. It was worth mentioning that, in comparison to 2D mesoporous silica, 3DOM silica displayed a more rapid release profile, which may be ascribed to the 3D interconnected pore networks and the highly accessible surface areas. The results obtained from the stability test indicated that the amorphous state of IMC entrapped in the 2D mesoporous silica (SBA-15 and MCM-41) has a better physical stability than in that of 3DOM silica. Moreover, the dissolution rate and stability of IMC loaded in 3DOM silica was closely related to the pore size of macroporous silica. The colorimetric 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Cell Counting Kit (CCK)-8 assays in combination with direct morphology observations demonstrated the good biocompatibility of nanoporous silica, especially for 3DOM silica and SBA-15. The present work encourages further study of the drug release properties and stability of drug entrapped in different pore architecture of silica in order to realize their potential in oral drug delivery.
机译:本研究的目的是比较具有不同孔结构的纳米多孔二氧化硅的药物释放特性和稳定性,以此作为改善难溶性药物递送的基质。为此,使用具有不同尺寸(200 nm和500 nm)的3D连续且相互连接的3D大孔的三维有序大孔(3DOM)二氧化硅和经典的中孔二氧化硅(即Mobil Composition of Matter [MCM] -41和Santa Barbara Amorphous [SBA]) [-15] [-15]成功地制备了具有良好顺序的二维(2D)圆柱中孔,然后通过溶剂沉积法将模型药物消炎痛(IMC)加载。应用扫描电子显微镜(SEM),N2吸附,差示扫描量热法(DSC)和X射线衍射(XRD)来系统表征所有IMC负载的纳米多孔二氧化硅配方,证明IMC成功地包含在纳米孔中,结晶度降低,最终加速了IMC的解散。值得一提的是,与2D中孔二氧化硅相比,3DOM二氧化硅显示出更快的释放曲线,这可能归因于3D互连的孔网络和高度可及的表面积。从稳定性测试中获得的结果表明,包裹在2D介孔二氧化硅(SBA-15和MCM-41)中的IMC的非晶态具有比3DOM二氧化硅更好的物理稳定性。此外,IMC在3DOM二氧化硅中的溶解速率和稳定性与大孔二氧化硅的孔径密切相关。比色法3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT)和细胞计数试剂盒(CCK)-8分析法与直接形态学观察相结合,证明了纳米多孔二氧化硅具有良好的生物相容性,特别是适用于3DOM硅胶和SBA-15。当前的工作鼓励进一步研究在不同的二氧化硅孔结构中截留的药物的释放特性和稳定性,以实现其在口服药物输送中的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号